nodes	percent_of_prediction	percent_of_DWPC	metapath
Benzatropine—SLC6A3—attention deficit hyperactivity disorder	0.853	1	CbGaD
Benzatropine—CHRM2—forebrain—attention deficit hyperactivity disorder	0.00124	0.0785	CbGeAlD
Benzatropine—SLC6A3—forebrain—attention deficit hyperactivity disorder	0.00124	0.0782	CbGeAlD
Benzatropine—CHRM1—forebrain—attention deficit hyperactivity disorder	0.00113	0.0714	CbGeAlD
Benzatropine—CHRM2—cardiovascular system—attention deficit hyperactivity disorder	0.00105	0.0663	CbGeAlD
Benzatropine—Diphenylpyraline—SLC6A3—attention deficit hyperactivity disorder	0.00099	0.155	CrCbGaD
Benzatropine—CHRM1—cardiovascular system—attention deficit hyperactivity disorder	0.000958	0.0604	CbGeAlD
Benzatropine—Cinnarizine—CACNA1C—attention deficit hyperactivity disorder	0.000918	0.144	CrCbGaD
Benzatropine—Reboxetine—SLC6A4—attention deficit hyperactivity disorder	0.000897	0.14	CrCbGaD
Benzatropine—SLC6A3—midbrain—attention deficit hyperactivity disorder	0.000819	0.0517	CbGeAlD
Benzatropine—HRH1—forebrain—attention deficit hyperactivity disorder	0.00072	0.0454	CbGeAlD
Benzatropine—CHRM2—nervous system—attention deficit hyperactivity disorder	0.000675	0.0426	CbGeAlD
Benzatropine—SLC6A3—nervous system—attention deficit hyperactivity disorder	0.000673	0.0425	CbGeAlD
Benzatropine—CHRM2—central nervous system—attention deficit hyperactivity disorder	0.00065	0.041	CbGeAlD
Benzatropine—SLC6A3—central nervous system—attention deficit hyperactivity disorder	0.000648	0.0409	CbGeAlD
Benzatropine—SLC6A3—cerebellum—attention deficit hyperactivity disorder	0.000634	0.04	CbGeAlD
Benzatropine—CHRM1—nervous system—attention deficit hyperactivity disorder	0.000615	0.0388	CbGeAlD
Benzatropine—CHRM1—central nervous system—attention deficit hyperactivity disorder	0.000592	0.0373	CbGeAlD
Benzatropine—Modafinil—SLC6A3—attention deficit hyperactivity disorder	0.000562	0.0879	CrCbGaD
Benzatropine—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.000548	0.0346	CbGeAlD
Benzatropine—Atomoxetine—HTR1B—attention deficit hyperactivity disorder	0.000535	0.0837	CrCbGaD
Benzatropine—CHRM2—brain—attention deficit hyperactivity disorder	0.000516	0.0326	CbGeAlD
Benzatropine—SLC6A3—brain—attention deficit hyperactivity disorder	0.000515	0.0325	CbGeAlD
Benzatropine—Benzphetamine—SLC6A3—attention deficit hyperactivity disorder	0.000487	0.0762	CrCbGaD
Benzatropine—Atomoxetine—SLC6A3—attention deficit hyperactivity disorder	0.000483	0.0756	CrCbGaD
Benzatropine—Benzphetamine—ADRA2A—attention deficit hyperactivity disorder	0.000478	0.0747	CrCbGaD
Benzatropine—CHRM1—brain—attention deficit hyperactivity disorder	0.00047	0.0296	CbGeAlD
Benzatropine—Cinnarizine—DRD2—attention deficit hyperactivity disorder	0.000404	0.0632	CrCbGaD
Benzatropine—HRH1—nervous system—attention deficit hyperactivity disorder	0.000391	0.0247	CbGeAlD
Benzatropine—HRH1—central nervous system—attention deficit hyperactivity disorder	0.000376	0.0237	CbGeAlD
Benzatropine—Atomoxetine—SLC6A4—attention deficit hyperactivity disorder	0.000361	0.0565	CrCbGaD
Benzatropine—HRH1—brain—attention deficit hyperactivity disorder	0.000299	0.0188	CbGeAlD
Benzatropine—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.000297	0.0188	CbGeAlD
Benzatropine—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.000286	0.0181	CbGeAlD
Benzatropine—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.00028	0.0177	CbGeAlD
Benzatropine—Atomoxetine—HTR2A—attention deficit hyperactivity disorder	0.000278	0.0434	CrCbGaD
Benzatropine—CHRM1—Circadian rythm related genes—TPH2—attention deficit hyperactivity disorder	0.000277	0.00222	CbGpPWpGaD
Benzatropine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.000277	0.00222	CbGpPWpGaD
Benzatropine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.000276	0.00221	CbGpPWpGaD
Benzatropine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.000272	0.00218	CbGpPWpGaD
Benzatropine—SLC6A3—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000271	0.00217	CbGpPWpGaD
Benzatropine—CHRM2—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.000268	0.00214	CbGpPWpGaD
Benzatropine—CHRM2—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.000268	0.00214	CbGpPWpGaD
Benzatropine—CHRM2—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.000253	0.00202	CbGpPWpGaD
Benzatropine—CHRM2—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.000237	0.0019	CbGpPWpGaD
Benzatropine—SLC6A3—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000233	0.00187	CbGpPWpGaD
Benzatropine—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00023	0.00184	CbGpPWpGaD
Benzatropine—CYP2D6—brain—attention deficit hyperactivity disorder	0.000227	0.0143	CbGeAlD
Benzatropine—HRH1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.000224	0.00179	CbGpPWpGaD
Benzatropine—CHRM1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.000223	0.00179	CbGpPWpGaD
Benzatropine—CHRM1—Circadian rythm related genes—SLC6A4—attention deficit hyperactivity disorder	0.000221	0.00177	CbGpPWpGaD
Benzatropine—CHRM1—Circadian rythm related genes—DRD1—attention deficit hyperactivity disorder	0.000221	0.00177	CbGpPWpGaD
Benzatropine—CHRM2—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00022	0.00176	CbGpPWpGaD
Benzatropine—SLC6A3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000217	0.00174	CbGpPWpGaD
Benzatropine—HRH1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000215	0.00172	CbGpPWpGaD
Benzatropine—CHRM1—Circadian rythm related genes—DRD3—attention deficit hyperactivity disorder	0.000214	0.00172	CbGpPWpGaD
Benzatropine—CHRM1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000214	0.00172	CbGpPWpGaD
Benzatropine—SLC6A3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000214	0.00172	CbGpPWpGaD
Benzatropine—SLC6A3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000213	0.0017	CbGpPWpGaD
Benzatropine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000212	0.0017	CbGpPWpGaD
Benzatropine—CHRM2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000212	0.00169	CbGpPWpGaD
Benzatropine—HRH1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000211	0.00169	CbGpPWpGaD
Benzatropine—CHRM1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00021	0.00168	CbGpPWpGaD
Benzatropine—CHRM1—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.000208	0.00167	CbGpPWpGaD
Benzatropine—CHRM2—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.000207	0.00166	CbGpPWpGaD
Benzatropine—CHRM2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000207	0.00166	CbGpPWpGaD
Benzatropine—HRH1—IL-4 Signaling Pathway—EP300—attention deficit hyperactivity disorder	0.000207	0.00165	CbGpPWpGaD
Benzatropine—CHRM2—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.000201	0.00161	CbGpPWpGaD
Benzatropine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000196	0.00157	CbGpPWpGaD
Benzatropine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000195	0.00156	CbGpPWpGaD
Benzatropine—CHRM2—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.000194	0.00156	CbGpPWpGaD
Benzatropine—CHRM1—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.000194	0.00155	CbGpPWpGaD
Benzatropine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000193	0.00154	CbGpPWpGaD
Benzatropine—HRH1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000192	0.00154	CbGpPWpGaD
Benzatropine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000191	0.00153	CbGpPWpGaD
Benzatropine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000189	0.00151	CbGpPWpGaD
Benzatropine—CHRM2—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.000187	0.0015	CbGpPWpGaD
Benzatropine—CHRM2—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.000184	0.00147	CbGpPWpGaD
Benzatropine—HRH1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000182	0.00146	CbGpPWpGaD
Benzatropine—CHRM2—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.000181	0.00145	CbGpPWpGaD
Benzatropine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000181	0.00145	CbGpPWpGaD
Benzatropine—HRH1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000181	0.00145	CbGpPWpGaD
Benzatropine—CHRM1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000181	0.00145	CbGpPWpGaD
Benzatropine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000179	0.00143	CbGpPWpGaD
Benzatropine—CHRM2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000178	0.00143	CbGpPWpGaD
Benzatropine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000176	0.00141	CbGpPWpGaD
Benzatropine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000176	0.00141	CbGpPWpGaD
Benzatropine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000173	0.00139	CbGpPWpGaD
Benzatropine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000173	0.00139	CbGpPWpGaD
Benzatropine—CHRM1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000173	0.00138	CbGpPWpGaD
Benzatropine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000171	0.00137	CbGpPWpGaD
Benzatropine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00017	0.00137	CbGpPWpGaD
Benzatropine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00017	0.00136	CbGpPWpGaD
Benzatropine—CHRM2—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.000169	0.00135	CbGpPWpGaD
Benzatropine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000168	0.00135	CbGpPWpGaD
Benzatropine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000168	0.00134	CbGpPWpGaD
Benzatropine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000167	0.00134	CbGpPWpGaD
Benzatropine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000165	0.00132	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000165	0.00132	CbGpPWpGaD
Benzatropine—SLC6A3—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000164	0.00132	CbGpPWpGaD
Benzatropine—CHRM2—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000164	0.00132	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000164	0.00131	CbGpPWpGaD
Benzatropine—SLC6A3—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000163	0.00131	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000162	0.0013	CbGpPWpGaD
Benzatropine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000159	0.00128	CbGpPWpGaD
Benzatropine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000159	0.00127	CbGpPWpGaD
Benzatropine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000157	0.00126	CbGpPWpGaD
Benzatropine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000156	0.00125	CbGpPWpGaD
Benzatropine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000155	0.00124	CbGpPWpGaD
Benzatropine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000153	0.00123	CbGpPWpGaD
Benzatropine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000151	0.00121	CbGpPWpGaD
Benzatropine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00015	0.0012	CbGpPWpGaD
Benzatropine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000149	0.00119	CbGpPWpGaD
Benzatropine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000148	0.00119	CbGpPWpGaD
Benzatropine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000148	0.00118	CbGpPWpGaD
Benzatropine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000147	0.00117	CbGpPWpGaD
Benzatropine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000146	0.00117	CbGpPWpGaD
Benzatropine—HRH1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000146	0.00117	CbGpPWpGaD
Benzatropine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000146	0.00117	CbGpPWpGaD
Benzatropine—CHRM1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000146	0.00117	CbGpPWpGaD
Benzatropine—HRH1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.000144	0.00116	CbGpPWpGaD
Benzatropine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000144	0.00115	CbGpPWpGaD
Benzatropine—CHRM1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.000144	0.00115	CbGpPWpGaD
Benzatropine—CHRM2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000144	0.00115	CbGpPWpGaD
Benzatropine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000137	0.00109	CbGpPWpGaD
Benzatropine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000136	0.00109	CbGpPWpGaD
Benzatropine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000134	0.00108	CbGpPWpGaD
Benzatropine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.000129	0.00103	CbGpPWpGaD
Benzatropine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.000129	0.00103	CbGpPWpGaD
Benzatropine—HRH1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000128	0.00102	CbGpPWpGaD
Benzatropine—CHRM1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000127	0.00102	CbGpPWpGaD
Benzatropine—CHRM2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000126	0.00101	CbGpPWpGaD
Benzatropine—CYP2C19—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000123	0.000986	CbGpPWpGaD
Benzatropine—CYP2C19—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000122	0.000979	CbGpPWpGaD
Benzatropine—HRH1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000122	0.000973	CbGpPWpGaD
Benzatropine—CYP2C19—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000121	0.000973	CbGpPWpGaD
Benzatropine—CHRM1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000121	0.00097	CbGpPWpGaD
Benzatropine—CHRM2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00012	0.000958	CbGpPWpGaD
Benzatropine—HRH1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000119	0.000954	CbGpPWpGaD
Benzatropine—CHRM1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000119	0.000951	CbGpPWpGaD
Benzatropine—HRH1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000119	0.000951	CbGpPWpGaD
Benzatropine—CHRM1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000118	0.000947	CbGpPWpGaD
Benzatropine—CHRM2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000117	0.000938	CbGpPWpGaD
Benzatropine—CHRM2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000117	0.000935	CbGpPWpGaD
Benzatropine—HRH1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000115	0.000921	CbGpPWpGaD
Benzatropine—CHRM1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000115	0.000918	CbGpPWpGaD
Benzatropine—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000113	0.000907	CbGpPWpGaD
Benzatropine—CHRM2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000113	0.000906	CbGpPWpGaD
Benzatropine—HRH1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000113	0.000905	CbGpPWpGaD
Benzatropine—CHRM1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000113	0.000902	CbGpPWpGaD
Benzatropine—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000112	0.000901	CbGpPWpGaD
Benzatropine—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000112	0.000895	CbGpPWpGaD
Benzatropine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000112	0.000894	CbGpPWpGaD
Benzatropine—HRH1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000112	0.000894	CbGpPWpGaD
Benzatropine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000111	0.000891	CbGpPWpGaD
Benzatropine—CHRM1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000111	0.000891	CbGpPWpGaD
Benzatropine—CHRM2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000111	0.00089	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00011	0.000884	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00011	0.000881	CbGpPWpGaD
Benzatropine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00011	0.000879	CbGpPWpGaD
Benzatropine—CHRM2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00011	0.000879	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000109	0.00087	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000108	0.000866	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000108	0.000863	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000106	0.000852	CbGpPWpGaD
Benzatropine—HRH1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000104	0.000833	CbGpPWpGaD
Benzatropine—CHRM1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000104	0.00083	CbGpPWpGaD
Benzatropine—CHRM2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000102	0.000819	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	9.72e-05	0.000779	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	9.69e-05	0.000776	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	9.57e-05	0.000766	CbGpPWpGaD
Benzatropine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	9.56e-05	0.000766	CbGpPWpGaD
Benzatropine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	9.53e-05	0.000763	CbGpPWpGaD
Benzatropine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	9.41e-05	0.000753	CbGpPWpGaD
Benzatropine—CHRM2—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	8.7e-05	0.000697	CbGpPWpGaD
Benzatropine—HRH1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	8.25e-05	0.000661	CbGpPWpGaD
Benzatropine—CHRM1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	8.23e-05	0.000659	CbGpPWpGaD
Benzatropine—CHRM2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	8.12e-05	0.00065	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	7.59e-05	0.000608	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	7.57e-05	0.000606	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	7.5e-05	0.0006	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	7.47e-05	0.000598	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	7.47e-05	0.000598	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	7.38e-05	0.000591	CbGpPWpGaD
Benzatropine—HRH1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	7.28e-05	0.000583	CbGpPWpGaD
Benzatropine—CHRM1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	7.26e-05	0.000581	CbGpPWpGaD
Benzatropine—HRH1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	7.21e-05	0.000578	CbGpPWpGaD
Benzatropine—CHRM1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	7.2e-05	0.000576	CbGpPWpGaD
Benzatropine—CHRM1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	7.19e-05	0.000576	CbGpPWpGaD
Benzatropine—CHRM2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	7.16e-05	0.000574	CbGpPWpGaD
Benzatropine—CHRM2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	7.1e-05	0.000569	CbGpPWpGaD
Benzatropine—HRH1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	6.71e-05	0.000537	CbGpPWpGaD
Benzatropine—CHRM1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	6.69e-05	0.000535	CbGpPWpGaD
Benzatropine—CHRM2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	6.6e-05	0.000529	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	6.55e-05	0.000525	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	6.53e-05	0.000523	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	6.52e-05	0.000522	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	6.5e-05	0.000521	CbGpPWpGaD
Benzatropine—HRH1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	6.5e-05	0.00052	CbGpPWpGaD
Benzatropine—CHRM1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	6.48e-05	0.000519	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	6.45e-05	0.000516	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	6.42e-05	0.000514	CbGpPWpGaD
Benzatropine—CHRM2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	6.39e-05	0.000512	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	6.39e-05	0.000512	CbGpPWpGaD
Benzatropine—HRH1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	6.39e-05	0.000511	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	6.37e-05	0.00051	CbGpPWpGaD
Benzatropine—CHRM1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	6.36e-05	0.00051	CbGpPWpGaD
Benzatropine—HRH1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	6.31e-05	0.000505	CbGpPWpGaD
Benzatropine—CHRM1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	6.29e-05	0.000503	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	6.29e-05	0.000503	CbGpPWpGaD
Benzatropine—CHRM2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	6.28e-05	0.000503	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	6.26e-05	0.000502	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	6.24e-05	0.0005	CbGpPWpGaD
Benzatropine—CHRM2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	6.21e-05	0.000497	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	6.16e-05	0.000494	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	6.09e-05	0.000488	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	6.07e-05	0.000486	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	5.99e-05	0.00048	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	5.9e-05	0.000472	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	5.88e-05	0.000471	CbGpPWpGaD
Benzatropine—HRH1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	5.87e-05	0.00047	CbGpPWpGaD
Benzatropine—CHRM1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	5.86e-05	0.000469	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	5.8e-05	0.000465	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	5.8e-05	0.000464	CbGpPWpGaD
Benzatropine—CHRM2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	5.78e-05	0.000463	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	5.78e-05	0.000463	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	5.73e-05	0.000459	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	5.71e-05	0.000457	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	5.71e-05	0.000457	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	5.63e-05	0.000451	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	5.33e-05	0.000427	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	5.32e-05	0.000426	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	5.25e-05	0.00042	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	5.04e-05	0.000403	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	4.63e-05	0.000371	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	4.43e-05	0.000355	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	4.41e-05	0.000353	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	4.36e-05	0.000349	CbGpPWpGaD
Benzatropine—HRH1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	4.11e-05	0.00033	CbGpPWpGaD
Benzatropine—CHRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	4.1e-05	0.000328	CbGpPWpGaD
Benzatropine—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	4.05e-05	0.000324	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	3.87e-05	0.00031	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	3.86e-05	0.000309	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	3.81e-05	0.000305	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	3.74e-05	0.000299	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	3.72e-05	0.000298	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	3.68e-05	0.000294	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	3.6e-05	0.000288	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	3.59e-05	0.000287	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	3.54e-05	0.000284	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	3.48e-05	0.000279	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	3.48e-05	0.000278	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	3.48e-05	0.000278	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	3.47e-05	0.000278	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	3.43e-05	0.000275	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	3.43e-05	0.000274	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	3.42e-05	0.000274	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	3.41e-05	0.000273	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	3.38e-05	0.000271	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	3.37e-05	0.00027	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	3.37e-05	0.00027	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	3.33e-05	0.000267	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	3.2e-05	0.000256	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	3.2e-05	0.000256	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	3.18e-05	0.000255	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	3.15e-05	0.000252	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	3.15e-05	0.000252	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	3.14e-05	0.000252	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	3.1e-05	0.000248	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.92e-05	0.000234	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.78e-05	0.000223	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.65e-05	0.000212	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.56e-05	0.000205	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.43e-05	0.000195	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.21e-05	0.000177	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.2e-05	0.000176	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.17e-05	0.000174	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	2.11e-05	0.000169	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	2.09e-05	0.000168	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	2.03e-05	0.000162	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	1.94e-05	0.000155	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	1.92e-05	0.000154	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.17e-05	9.36e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.17e-05	9.33e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.15e-05	9.21e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	9.03e-06	7.23e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	8.31e-06	6.65e-05	CbGpPWpGaD
